Tselios T - Search Results

1

IKKβ deletion from CNS macrophages increases neuronal excitability and accelerates the onset of EAE, while from peripheral macrophages reduces disease severity.

Avloniti M, Evangelidou M, Gomini M, Loupis T, Emmanouil M, Mitropoulou A, Tselios T, Lassmann H, Gruart A, Delgado-García JM, Probert L, Kyrargyri V. Avloniti M, et al. Among authors: tselios t. J Neuroinflammation. 2024 Jan 27;21(1):34. doi: 10.1186/s12974-024-03023-9. J Neuroinflammation. 2024. PMID: 38279130 Free PMC article.

2

Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions.

Dagkonaki A, Avloniti M, Evangelidou M, Papazian I, Kanistras I, Tseveleki V, Lampros F, Tselios T, Jensen LT, Möbius W, Ruhwedel T, Androutsou ME, Matsoukas J, Anagnostouli M, Lassmann H, Probert L. Dagkonaki A, et al. Among authors: tselios t. Front Immunol. 2020 Nov 19;11:575451. doi: 10.3389/fimmu.2020.575451. eCollection 2020. Front Immunol. 2020. PMID: 33329540 Free PMC article.

3

Maturation of circulating Ly6C^hiCCR2⁺ monocytes by mannan-MOG induces antigen-specific tolerance and reverses autoimmune encephalomyelitis.

Dagkonaki A, Papalambrou A, Avloniti M, Gkika A, Evangelidou M, Androutsou ME, Tselios T, Probert L. Dagkonaki A, et al. Among authors: tselios t. Front Immunol. 2022 Sep 9;13:972003. doi: 10.3389/fimmu.2022.972003. eCollection 2022. Front Immunol. 2022. PMID: 36159850 Free PMC article.

4

Neuronal I kappa B kinase beta protects mice from autoimmune encephalomyelitis by mediating neuroprotective and immunosuppressive effects in the central nervous system.

Emmanouil M, Taoufik E, Tseveleki V, Vamvakas SS, Tselios T, Karin M, Lassmann H, Probert L. Emmanouil M, et al. Among authors: tselios t. J Immunol. 2009 Dec 15;183(12):7877-89. doi: 10.4049/jimmunol.0900834. J Immunol. 2009. PMID: 20007573 Free PMC article.

5

Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB.

Taoufik E, Tseveleki V, Chu SY, Tselios T, Karin M, Lassmann H, Szymkowski DE, Probert L. Taoufik E, et al. Among authors: tselios t. Brain. 2011 Sep;134(Pt 9):2722-35. doi: 10.1093/brain/awr203. Brain. 2011. PMID: 21908876

6

A Cyclic Altered Peptide Analogue Based on Myelin Basic Protein 87-99 Provides Lasting Prophylactic and Therapeutic Protection Against Acute Experimental Autoimmune Encephalomyelitis.

Emmanouil M, Tseveleki V, Triantafyllakou I, Nteli A, Tselios T, Probert L. Emmanouil M, et al. Among authors: tselios t. Molecules. 2018 Jan 31;23(2):304. doi: 10.3390/molecules23020304. Molecules. 2018. PMID: 29385090 Free PMC article.

7

Characterization of Asparagine Deamidation in Immunodominant Myelin Oligodendrocyte Glycoprotein Peptide Potential Immunotherapy for the Treatment of Multiple Sclerosis.

Androutsou ME, Nteli A, Gkika A, Avloniti M, Dagkonaki A, Probert L, Tselios T, Golič Grdadolnik S. Androutsou ME, et al. Among authors: tselios t. Int J Mol Sci. 2020 Oct 13;21(20):7566. doi: 10.3390/ijms21207566. Int J Mol Sci. 2020. PMID: 33066323 Free PMC article.

8

Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.

Tseveleki V, Tselios T, Kanistras I, Koutsoni O, Karamita M, Vamvakas SS, Apostolopoulos V, Dotsika E, Matsoukas J, Lassmann H, Probert L. Tseveleki V, et al. Among authors: tselios t. Exp Neurol. 2015 May;267:254-67. doi: 10.1016/j.expneurol.2014.10.019. Epub 2014 Oct 30. Exp Neurol. 2015. PMID: 25447934

9

Divergent and convergent synthesis of polymannosylated dibranched antigenic peptide of the immunodominant epitope MBP(83-99).

Friligou I, Rizzolo F, Nuti F, Tselios T, Evangelidou M, Emmanouil M, Karamita M, Matsoukas J, Chelli M, Rovero P, Papini AM. Friligou I, et al. Among authors: tselios t. Bioorg Med Chem. 2013 Nov 1;21(21):6718-25. doi: 10.1016/j.bmc.2013.08.008. Epub 2013 Aug 13. Bioorg Med Chem. 2013. PMID: 23993671

10

Antagonistic effects of human cyclic MBP(87-99) altered peptide ligands in experimental allergic encephalomyelitis and human T-cell proliferation.

Tselios T, Apostolopoulos V, Daliani I, Deraos S, Grdadolnik S, Mavromoustakos T, Melachrinou M, Thymianou S, Probert L, Mouzaki A, Matsoukas J. Tselios T, et al. J Med Chem. 2002 Jan 17;45(2):275-83. doi: 10.1021/jm0102147. J Med Chem. 2002. PMID: 11784132

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page